Reading the launch
The AI-powered pharmaceutical company of the future. Synthesized two novel neurological drugs (PAC-832 for Alzheimer’s and PAC-3310 for schizophrenia) entirely using frontier AI models and liquid-handling robotics — with Pace Pharmaceuticals.
Reading trades.